SEARCH RESULT

Total Matching Records found : 202

Flagships adrift -Jayati Ghosh

The ICDS' plight is symptomatic of the problems plaguing the Union government's flagship schemes for the poor all over the country.   INDIA may be the only country in the world where we describe the ensuring of the basic socio-economic rights of the people in terms of “flagship schemes” that are seen as the benevolent contribution of governments. One problem with this approach is that the delivery of basic services is...

More »

Delete the errors to save the census by Swati Narayan

Unless data gathering for the Socio Economic and Caste Census is refined, the exercise could cast out the real claimants. Have the census enumerators recently knocked on your door with swanky tablet computers in hand? If they have, it's because they have begun to go door-to-door in most States to complete the final phase of the Socio Economic and Caste Census (SECC). This mammoth exercise is being coordinated by more than...

More »

What hit this land of plenty?-Sai Manish

75% of the youth. Every third student. 65% of all families in Punjab are in the throes of a sweeping drug addiction. With little or no hope in sight. THE RAILWAY barrier in Angarh, a locality in the border city of Amritsar in Punjab signals the end of too many things. The rule of law. The reign of sense. The fear of crime. The signs of normality. Even the divisions of...

More »

New panel for 'reliable' inflation, IIP data-Sidhartha

Under fire over data integrity issues, the government has tasked a panel to revise the wholesale price index (WPI) with the mandate to "enhance the reliability" of official statistics on all inflation measures.  The 31-member panel, to be headed by Planning Commission member Saumitra Chaudhuri, has also been asked to explore the possibility of getting a single agency to collect data for compiling WPI and industrial production that are hitherto dealt...

More »

A Strike against Pharma MNCs

-Economic and Political Weekly The compulsory licence for Nexavar is only the beginning of a new battle over drug prices. The grant of a compulsory licence (CL) to Natco Pharma, a relatively small Indian pharmaceutical company, to manufacture and sell the cancer drug sorafenib (Nexavar) has been rightly hailed as a major step forward for public health and the wider availability of life saving medicines.   The German pharmaceutical company Bayer holds the patent...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close